VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EVOEvotec SE
$2.74$973M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksEVOCash Flow

Evotec SE (EVO) Cash Flow Statement

23Y historyFree accessUpdated daily

Cash flow generation remains erratic and disconnected from earnings, highlighted by a 2026Q1 OCF/NI ratio of 0.02 and a free cash flow deficit of $6.4 million.

EVO Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03
Cash from Operations17.85M-9.06M18.22M36.44M205.81M122.24M44.72M42.22M156.24M10.83M67.36M15.65M-3.8M6.66M11.96M10.15M899K-21.85M-41.28M-31.67M-9.22M-2.14M-18.6M-14.02M
Operating CF Margin %--1.2%2.29%4.66%27.39%19.78%8.93%9.46%41.62%4.2%40.95%12.26%-4.24%7.75%13.7%12.66%1.63%-51.2%-104.2%-96.31%-13.7%-3.33%-960.46%-392.42%
Operating CF Growth %-36.22%-149.75%-50%-82.29%68.37%173.33%5.93%-72.98%1342.93%-83.93%330.39%512.19%-157.04%-44.33%17.85%1028.59%104.11%47.06%-30.33%-243.33%-331.68%88.51%-32.64%-
Net Income-196.02M-99.43M-196.08M-83.91M-175.66M215.51M6.25M37.31M84.06M24M26.84M16.52M-6.98M-25.43M2.48M6.65M2.98M-45.5M-78.29M-11.16M-36.3M-31.21M-29.46M-33.25M
Depreciation & Amortization49.53M95.55M101.62M92.98M83.2M67.61M56.06M48.8M31.29M20.77M11.89M11.94M8.54M9.16M8.82M6.61M5.51M4.78M5.13M8.94M9.61M16.4M2.14M2.03M
Stock-Based Compensation005.04M9.63M9.92M7.8M5.29M3.65M4.25M2.92M3.98M3.97M1.5M1.25M1.51M00960K1.68M1.02M1.13M749K00
Deferred Taxes014.11M2.1M3.32M21.7M5.07M7.49M6.74M-26.12M-6.14M-1.75M-6.67M-39K1.49M-8.29M0016.36M24.03M03.83M12.05M00
Other Non-Cash Items119.85M39.11M173.75M24.37M161.37M-171.47M6.51M14.61M-9.17M4.97M7.16M-13.61M12.07M26.89M4.9M-1.41M-3.32M2.76M7.89M-33.84M4.71M207K4.5M16.83M
Working Capital Changes44.49M-58.4M-68.21M-9.94M105.28M-2.28M-36.87M-68.9M71.93M-35.68M19.23M3.49M-18.88M-6.71M2.54M-1.71M-4.27M-1.21M-1.72M3.36M7.8M-329K4.23M365.25K
Change in Receivables0-27.6M00-53.68M-48.03M-4.18M-49.33M-1.85M-7.88M-4.11M4.42M-9.26M-2.48M-4.68M0-6.55M-2.2M7.43M00000
Change in Inventory0-9.18M00-4.41M-11.65M-3.63M-1.36M-283K814K-360K-5K-916K60K831K-1.1M-710K-249K-146K1.78M-137K-1.15M00
Change in Payables0-7.02M0024.55M31.34M2.17M-2.03M5.01M1.9M-1.3M-8.81M2.42M218K-3.85M01.52M-2.19M-9.63M00000
Cash from Investing169.6M159.86M-71.19M-13.29M-412.8M-243.85M-155.09M-86.63M-39.13M-269.03M-5.97M-23.42M2.98M-31.51M5.78M-15.07M-9.88M-2.08M61.05M21.3M19.37M12.37M-31.04M-21.5M
Capital Expenditures-65.93M-79.36M-117.47M-213.32M-181.35M-118.94M-99.07M-31.32M-27.87M-17.59M-10.15M-11.5M-5.28M-5.19M-10.18M-8.14M-2.43M-2.21M-3.51M-4.35M-2.56M-4.14M00
CapEx % of Revenue8.85%10.48%14.74%27.3%24.13%19.25%19.78%7.02%7.42%6.83%6.17%9%5.9%6.04%11.66%10.16%4.4%5.18%8.87%13.22%3.79%6.46%--
Acquisitions210.64M213.76M42.78M-20.16M-83.82M-21.09M-33.63M-52.15M5.17M-270.32M-43.44M37.11M-2.44M-1.03M-3M01.2M157K8.52M42.74M0-366K00
Investments------------------------
Other Investing23.33M0-2.78M8.22M3.03M-7.38M-6.24M-583K-2.14M691K44.45M-49.39M1.07M583K46K562K1K320K2.05M332K19K19.99M31.04M21.39M
Cash from Financing-89.88M-30.93M-161.42M71.96M-58.15M398.43M246.41M211.26M-77.76M240.72M-19.67M2.49M3.1M31.94M2.6M2.14M-3.37M1.52M-4.31M-1M16.11M25.94M54.06M34.8M
Debt Issued (Net)-34.24M-6.96M-152.07M84.6M-53.11M14.77M-5.16M209.36M-79.34M148.37M-19.72M1.07M4.25M-184K1.9M3.61M-3.49M1.29M-1.73M23K-1.85M-2.52M00
Equity Issued (Net)-1.38M-1.27M00355K404.32M249.97M0090.25M01.97M030.03M-113K-67K123K234K088K18.68M28.46M53.17M36.13M
Dividends Paid00000000000-551K-1.81M-278K00-383K-4.06M0-6.04M-7.44M000
Share Repurchases0000000000000-109K-113K-67K-96K-44K0-59K-83K000
Other Financing-54.26M-22.71M-9.35M-12.63M-5.39M-20.66M1.59M1.9M1.58M2.11M53K-551K-1.16M2.09M-2.19M-1.4M00-2.58M-1.11M-727K0885.22K-1.33M
Net Change in Cash99.46M148.32M-204.52M95.75M-284.17M276.75M145.55M167.98M42.04M-16.92M39.44M-4.21M3.07M6.58M21.29M-3.31M-11.84M-22.14M17.07M-20.2M26.54M37.27M2.82M-2.32M
Free Cash Flow-44.92M-78.74M-114.02M-179.56M24.46M3.29M-54.35M10.31M128.37M-6.76M57.21M4.16M-9.08M1.47M1.78M2.01M-1.53M-24.07M-44.79M-36.02M-11.78M-6.28M-18.6M-14.02M
FCF Margin %-6.03%-10.4%-14.31%-22.98%3.25%0.53%-10.85%2.31%34.2%-2.62%34.78%3.25%-10.14%1.71%2.04%2.5%-2.78%-56.38%-113.07%-109.54%-17.49%-9.8%-960.46%-392.42%
FCF Growth %49.55%30.94%36.5%-834.18%642.47%106.06%-627.12%-91.97%1999.29%-111.81%1276.92%145.76%-718.88%-17.68%-11.21%230.83%93.63%46.27%-24.35%-205.75%-87.57%66.23%-32.64%-
FCF per Share-0.13-0.22-0.32-0.510.070.01-0.180.030.44-0.020.220.02-0.030.010.010.01-0.01-0.11-0.24-0.25-0.20-0.12-0.43-7.80
FCF Conversion (FCF/Net Income)0.23x0.09x-0.09x-0.43x-1.17x0.57x7.12x1.11x1.86x0.45x2.45x0.95x0.54x-0.26x4.83x1.50x0.28x0.48x0.53x2.84x0.28x0.06x0.63x0.42x
Interest Paid943K00000000000000000000000
Taxes Paid000000000000000000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetStrained
Cash FlowBurning
Top Statement Risk

High cash burn volatility

Earnings Quality Remains Highly Disconnected

As reported in financial statements, Evotec's operating cash flow frequently diverges from net income, with the 2026Q1 OCF/NI ratio of 0.02 highlighting a persistent inability to convert accounting losses into meaningful cash generation, suggesting that the company's reported earnings are heavily influenced by non-cash accounting adjustments.

The consistent gap between net income and operating cash flow indicates that the company's core operations are not yet self-funding. Investors should monitor whether this disconnect is driven by aggressive revenue recognition or the timing of milestone payments, as the current trend suggests that cash generation remains decoupled from operational performance.

Free Cash Flow Volatility Persists

Based on recent quarterly data, Evotec's free cash flow trajectory remains erratic, swinging from a peak of $49.1M in 2024Q4 to a deficit of $6.4M in 2026Q1, which underscores the inherent instability of a business model reliant on lumpy, project-based milestone payments rather than recurring revenue.

The inability to maintain positive free cash flow suggests that the company's high fixed-cost base is not being adequately covered by its current service volume. This volatility may indicate that the company is struggling to achieve the scale necessary to transition from a cash-burning growth phase to a self-sustaining operational model.

Capital Intensity Weighs on Liquidity

According to historical filings, Evotec's capital expenditure as a percentage of revenue reached as high as 31.5% in 2023Q4, reflecting the heavy investment required to maintain its J.POD biologics manufacturing facilities, which continues to exert significant pressure on the company's overall cash position and liquidity profile.

The high capital intensity suggests that the company is locked into a cycle of continuous reinvestment to maintain its technological edge. If these investments do not yield a commensurate increase in high-margin royalty income, the company may face ongoing challenges in achieving a sustainable return on its invested capital.

Working Capital Swings Mask Instability

As evidenced by the $72.7M working capital inflow in 2026Q1, Evotec's cash flow is frequently bolstered by volatile changes in working capital, which often obscures the underlying operational cash burn and makes it difficult to assess the true efficiency of the company's collection and payment cycles.

The reliance on working capital fluctuations to manage liquidity suggests that the company's cash management is highly sensitive to the timing of client payments and milestone receipts. Investors should be cautious, as these inflows are often temporary and do not represent a permanent improvement in the company's fundamental cash-generating capability.

Capital Allocation Prioritizes Asset Expansion

Based on reported figures, Evotec has directed its limited capital toward facility expansion and strategic acquisitions rather than shareholder returns, with minimal dividend or buyback activity observed, indicating that management remains focused on scaling the platform despite the ongoing pressure on the company's cash reserves.

The lack of shareholder-friendly capital allocation is consistent with a company in a high-growth, capital-intensive phase. However, given the persistent negative operating margins, this strategy warrants further investigation into whether the expected returns on these investments will be sufficient to justify the continued dilution or debt accumulation risks.

EVO — Frequently Asked Questions

Quick answers to the most common questions about buying EVO stock.

How much cash does Evotec SE (EVO) generate from operations?

Evotec SE (EVO) generated $-9.1M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Evotec SE's free cash flow?

Evotec SE (EVO) reported negative free cash flow of $78.7M in 2025, indicating capital requirements exceeded cash from operations.

What is Evotec SE's capital expenditure (CapEx)?

Evotec SE (EVO) spent $79.4M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.